This study investigated the influence of action-associated predictive processes on visual ERPs. In two experiments, we sought evidence for sensory attenuation (SA) indexed by ERP amplitude reductions for self-induced stimuli when compared to passive viewing of the same images. We assessed if SA is (a) present for both ecological and abstract stimuli (pictures depicting hands or checkerboards), (b) modulated by the degree of stimulus predictability (certain or uncertain action-effect contingencies), and (c) sensitive to laterality of hand movements (dominant or subdominant hand actions). We found reduced occipital responses in the early 77-90 ms time interval (C1 component), irrespective of stimulus type, predictability, or the laterality of hand movements. However, the subsequent P1 component was increased (rather than reduced) for all action-associated stimuli. In addition, this P1 effect was influenced by the degree of stimulus predictability for ecological stimuli only. Finally, the posterior N1 component was not modulated by self-initiated actions. Overall, our findings indicate that movement-related predictive processes attenuate early visual responses. Moreover, we propose that amplitude modulations in the P1 time range reflect the interaction between expectation-based SA and attention-associated amplitude enhancements. These results can have implications for assessing the influence of action-associated predictions on visual processing in psychiatric disorders characterized by aberrant sensory predictions and alterations in hemispheric asymmetry, such as schizophrenia.
More than a dozen studies of the Complex Trial Protocol (CTP) version of the P300-based Concealed Information Test have been published since its introduction (Rosenfeld et al., 2008), and it has been fairly consistently proven to provide high accuracy and strong resistance to countermeasures . However, no independent authors have verified these findings until now. In the present, first independent study, we corroborate the accuracy and countermeasure-resistance of the CTP, when the probe item (critical presented information, e.g., crime detail; P) vs. all irrelevant items (Iall) comparison is used for classifying participants as guilty or innocent, but we also show that the CTP is severely vulnerable to countermeasures, when the P vs. the irrelevant item with the largest P300 responses (Imax) comparison is used.This latter measure can be defeated by creating "oddball" items among the irrelevant items (through targeting them with covert responses), and thereby making their P300 responses statistically indistinguishable from those of the probe item. Practical implications are discussed.
More than a dozen studies of the Complex Trial Protocol (CTP) version of the P300-based Concealed Information Test have been published since its introduction (Rosenfeld et al., 2008), and it has been fairly consistently proven to provide high accuracy and strong resistance to countermeasures . However, no independent authors have verified these findings until now. In the present, first independent study, we corroborate the accuracy and countermeasure-resistance of the CTP, when the probe item (critical presented information, e.g., crime detail; P) vs. all irrelevant items (Iall) comparison is used for classifying participants as guilty or innocent, but we also show that the CTP is severely vulnerable to countermeasures, when the P vs. the irrelevant item with the largest P300 responses (Imax) comparison is used.This latter measure can be defeated by creating "oddball" items among the irrelevant items (through targeting them with covert responses), and thereby making their P300 responses statistically indistinguishable from those of the probe item. Practical implications are discussed.
Background: Impulsivity and compulsivity are related to emotional and social maladjustment and often underlie psychiatric disorders. Recently, alterations in microbiota composition have been shown to have implications for brain development and social behavior via the microbiota-gut-brain axis. However, the exact mechanisms are not fully identified. Recent evidence suggests the modulatory effect of synbiotics on gut microbiota and the contribution of these agents in ameliorating symptoms of many psychiatric diseases. To date, no randomized controlled trial has been performed to establish the feasibility and efficacy of this intervention targeting the reduction of impulsivity and compulsivity. We hypothesize that supplementation with synbiotics may be an effective treatment in adults with high levels of impulsivity and/or compulsivity. Methods/design: This is a prospective, multicenter, double-blind, randomized controlled trial with two arms: treatment with a synbiotic formula versus placebo treatment. The primary outcome is the response rate at the end of the placebocontrolled phase (response defined as a Clinical Global Impression-Improvement Scale score of 1 or 2 = very much improved or much improved, plus a reduction in the Affective Reactivity Index total score of at least 30% compared with baseline). A total of 180 participants with highly impulsive behavior and a diagnosis of attention deficit/hyperactivity disorder (ADHD) and/or borderline personality disorder, aged 18-65 years old, will be screened at three study centers. Secondary outcome measures, including changes in general psychopathology, ADHD symptoms, neurocognitive function, somatic parameters, physical activity, nutritional intake, and health-related quality of life, will be explored at assessments before, during, and at the end of the intervention. The effect of the intervention on genetics, microbiota, and several blood biomarkers will also be assessed. Gastrointestinal symptoms and somatic complaints will additionally be explored at 1-week follow-up. Discussion: This is the first randomized controlled trial to determine the effects of supplementation with synbiotics on reducing impulsive and compulsive behavior. This clinical trial can contribute to explaining the mechanisms involved in the crosstalk between the intestinal microbiome and the brain. If effects can be established by reducing impulsive and compulsive behavior, new cost-effective treatments might become available to these patients.
This study investigated the influence of action-associated predictive processes on visual event-related potentials (ERPs). In two experiments (N=17 and N=19), we sought evidence for sensory attenuation (SA) indexed by ERP amplitude reductions for self-induced stimuli when compared to passive viewing of the same images. We assessed if SA (1) is stronger for ecologically valid versus abstract stimuli (by comparing ERPs to pictures depicting hands versus checkerboards), (2) is specific to stimulus identity (certain versus uncertain action-effect contingencies), and (3) is sensitive to laterality of hand movements (dominant versus subdominant hand actions). We found reduced occipital responses for self-triggered hand stimuli very early, between 80-90 ms (C1 component), but this effect was absent for checkerboards. On the contrary, the P1 component (100-140 ms) was enhanced for all action-associated stimuli, and this effect proved to be sensitive to stimulus predictability for hands only. The parietal N1 component (170-190 ms) showed amplitude enhancement after right-hand movements for checkerboards only. Overall, our findings indicate that action-associated predictive processes attenuate early cortical responses to ecologically valid visual stimuli. Moreover, we propose that subsequent ERPs show amplitude enhancement that might result from the interaction between expectation-based SA and attention. Movement-initiated modulation of visual ERPs does not appear to show strong lateralization in healthy individuals, although the absence of lateralized effects cannot be excluded. These results can have implications for assessing the influence of action-associated predictions on visual processing in psychiatric disorders characterized by aberrant sensory predictions and alterations in hemispheric asymmetry, such as schizophrenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.